"The restructuring affects employees predominantly in technical positions and is largely focused on internally-facing roles as the company evolves from development stage to commercial stage," the SEC filing read in part. The company reported having 131 employees, 84 of whom worked in research, development and manufacturing.
https://www.stamfordadvocate.com/business/article/hyperfine-layoffs-medical-devices-ct-guilford-20063626.php